These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Glycogen synthase kinase 3: a drug target for CNS therapies. Bhat RV; Budd Haeberlein SL; Avila J J Neurochem; 2004 Jun; 89(6):1313-7. PubMed ID: 15189333 [TBL] [Abstract][Full Text] [Related]
5. Effects of lithium on second messenger systems in the brain. Mørk A; Geisler A; Hollund P Pharmacol Toxicol; 1992; 71 Suppl 1():4-17. PubMed ID: 1336196 [No Abstract] [Full Text] [Related]
6. [Molecular mechanisms of biological effects of lithium]. Patocka J; Klár I; Strunecká A Cesk Fysiol; 2002 Aug; 51(3):122-8. PubMed ID: 12402788 [TBL] [Abstract][Full Text] [Related]
7. A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder. McQuillin A; Rizig M; Gurling HM Pharmacogenet Genomics; 2007 Aug; 17(8):605-17. PubMed ID: 17622937 [TBL] [Abstract][Full Text] [Related]
9. The common inositol-reversible effect of mood stabilizers on neurons does not involve GSK3 inhibition, myo-inositol-1-phosphate synthase or the sodium-dependent myo-inositol transporters. Di Daniel E; Cheng L; Maycox PR; Mudge AW Mol Cell Neurosci; 2006; 32(1-2):27-36. PubMed ID: 16531065 [TBL] [Abstract][Full Text] [Related]
10. Lithium in Medicine: Mechanisms of Action. Mota de Freitas D; Leverson BD; Goossens JL Met Ions Life Sci; 2016; 16():557-84. PubMed ID: 26860311 [TBL] [Abstract][Full Text] [Related]
11. Ziskind-Somerfeld Research Award 1993. Biochemical, behavioral, and clinical studies of the role of inositol in lithium treatment and depression. Kofman O; Belmaker RH Biol Psychiatry; 1993 Dec; 34(12):839-52. PubMed ID: 8110911 [TBL] [Abstract][Full Text] [Related]
12. Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders. Bauer M; Alda M; Priller J; Young LT; Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S250-4. PubMed ID: 14677087 [TBL] [Abstract][Full Text] [Related]
13. Differential effect of lithium on the circadian oscillator in young and old hamsters. Iwahana E; Hamada T; Uchida A; Shibata S Biochem Biophys Res Commun; 2007 Mar; 354(3):752-6. PubMed ID: 17254554 [TBL] [Abstract][Full Text] [Related]
14. [Pharmacology, biochemistry and therapeutic use of lithium salts]. Rizzo M Recenti Prog Med; 1974 Sep; 57(3):214-39. PubMed ID: 4605852 [No Abstract] [Full Text] [Related]
15. Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited. Harwood AJ Mol Psychiatry; 2005 Jan; 10(1):117-26. PubMed ID: 15558078 [TBL] [Abstract][Full Text] [Related]
16. Opposite effects of lithium and valproic acid on trophic factor deprivation-induced glycogen synthase kinase-3 activation, c-Jun expression and neuronal cell death. Jin N; Kovács AD; Sui Z; Dewhurst S; Maggirwar SB Neuropharmacology; 2005 Mar; 48(4):576-83. PubMed ID: 15755485 [TBL] [Abstract][Full Text] [Related]
17. Manipulation of inositol-linked second messenger systems as a therapeutic strategy in psychiatry. Belmaker RH; Bersudsky Y; Benjamin J; Agam G; Levine J; Kofman O Adv Biochem Psychopharmacol; 1995; 49():67-84. PubMed ID: 7653335 [No Abstract] [Full Text] [Related]
18. Lithium for the treatment of affective illnesses. Rostykus PS; Stillner V Alaska Med; 1979 May; 21(3):33-7. PubMed ID: 474942 [No Abstract] [Full Text] [Related]